Literature DB >> 23790724

No differential attrition was found in randomized controlled trials published in general medical journals: a meta-analysis.

Rik Crutzen1, Wolfgang Viechtbauer, Daniel Kotz, Mark Spigt.   

Abstract

OBJECTIVE: Differential attrition is regarded as a major threat to the internal validity of a randomized controlled trial (RCT). This study identifies the degree of differential attrition in RCTs covering a broad spectrum of clinical areas and factors that are related to this. STUDY DESIGN AND
SETTING: A PubMed search was conducted to obtain a random sample of 100 RCTs published between 2008 and 2010 in journals from the ISI Web of Knowledge(SM) category of medicine, general and internal. Eligibility criteria for selecting studies were primary publications of two-arm parallel randomized clinical trials, containing human participants and one or multiple follow-up measurements whose availability depended on the patients' willingness to participate.
RESULTS: A significant amount of differential attrition was observed in 8% of the trials. The average differential attrition rate was 0.99 (95% confidence interval: 0.97-1.01), indicating no general difference in attrition rates between intervention and control groups. Moreover, no indication of heterogeneity was found, suggesting that the occurrence of differential attrition in the published literature is mostly a chance finding, unrelated to any particular design factors.
CONCLUSION: Differential attrition did not generally occur in RCTs covering a broad spectrum of clinical areas within general and internal medicine.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bias; Differential attrition; Internal validity; Loss to follow-up; Meta-analysis; RCT

Mesh:

Year:  2013        PMID: 23790724     DOI: 10.1016/j.jclinepi.2013.03.019

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  8 in total

Review 1.  Missing data in randomized controlled trials testing palliative interventions pose a significant risk of bias and loss of power: a systematic review and meta-analyses.

Authors:  Jamilla A Hussain; Ian R White; Dean Langan; Miriam J Johnson; David C Currow; David J Torgerson; Martin Bland
Journal:  J Clin Epidemiol       Date:  2015-12-21       Impact factor: 6.437

2.  Factors associated with study attrition in a pilot randomised controlled trial to explore the role of exercise-assisted reduction to stop (EARS) smoking in disadvantaged groups.

Authors:  T P Thompson; C J Greaves; R Ayres; P Aveyard; F C Warren; R Byng; R S Taylor; J L Campbell; M Ussher; S Michie; R West; A H Taylor
Journal:  Trials       Date:  2016-10-27       Impact factor: 2.279

3.  Best practice guidance for the use of strategies to improve retention in randomized trials developed from two consensus workshops.

Authors:  Valerie Brueton; Sally P Stenning; Fiona Stevenson; Jayne Tierney; Greta Rait
Journal:  J Clin Epidemiol       Date:  2017-05-22       Impact factor: 6.437

Review 4.  A Review of Recruitment, Adherence and Drop-Out Rates in Omega-3 Polyunsaturated Fatty Acid Supplementation Trials in Children and Adolescents.

Authors:  Inge S M van der Wurff; Barbara J Meyer; Renate H M de Groot
Journal:  Nutrients       Date:  2017-05-10       Impact factor: 5.717

5.  Efficacy of a Web-Based Self-Management Enhancing Program for Patients with Rheumatoid Arthritis: Explorative Randomized Controlled Trial.

Authors:  Rixt Zuidema; Sandra van Dulmen; Maria Nijhuis-van der Sanden; Inger Meek; Cornelia van den Ende; Jaap Fransen; Betsie van Gaal
Journal:  J Med Internet Res       Date:  2019-04-30       Impact factor: 5.428

6.  Evaluation of a Web-Based Self-Management Program for Patients With Cardiovascular Disease: Explorative Randomized Controlled Trial.

Authors:  Marscha M Engelen; Sandra van Dulmen; Saskia Puijk-Hekman; Hester Vermeulen; Maria Wg Nijhuis-van der Sanden; Sebastian Jh Bredie; Betsie Gi van Gaal
Journal:  J Med Internet Res       Date:  2020-07-24       Impact factor: 5.428

7.  Historical Benchmarks for Quality Tolerance Limits Parameters in Clinical Trials.

Authors:  Marcin Makowski; Ruma Bhagat; Soazig Chevalier; Steven A Gilbert; Dagmar R Görtz; Marta Kozińska; Patrick Nadolny; Melissa Suprin; Sabine Turri
Journal:  Ther Innov Regul Sci       Date:  2021-08-27       Impact factor: 1.778

8.  Design, planning and implementation lessons learnt from a surgical multi-centre randomised controlled trial.

Authors:  Katie Biggs; Daniel Hind; Mike Bradburn; Lizzie Swaby; Steve Brown
Journal:  Trials       Date:  2019-11-01       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.